Nicolas Limal
Overview
Explore the profile of Nicolas Limal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maillet F, Nguyen Y, Espitia O, Perard L, Salvarani C, Riviere E, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39898825
Objectives: To describe the characteristics and outcome of patients with the association of large vessel vasculitis (LVV, Takayasu arteritis [TA] or giant cell arteritis [GCA]) and inflammatory bowel disease (IBD)....
2.
Lefevre G, Bleuse S, Puyade M, Moulis G, Neel A, Abisror N, et al.
Allergy
. 2025 Jan;
PMID: 39757773
Background: Hypereosinophilic syndromes (HES) are a heterogenous group of eosinophilic disorders. To date, only retrospective studies of limited sample-size and/or follow-up duration are available. Methods: The COHESion study is a...
3.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood
. 2024 Oct;
145(2):244-247.
PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
4.
Dubois S, Layese R, Limal N, Languille L, Kini-Matondo W, Mahevas M, et al.
Br J Haematol
. 2024 Oct;
205(6):2425-2431.
PMID: 39389921
Intravenous immunoglobulin (IVIg) is the gold standard treatment for severe cases of immune thrombocytopenia (ITP). However, its cost, limited duration of efficacy and market supply tension have led French guidelines...
5.
Murarasu A, Guettrot-Imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, et al.
Lancet Rheumatol
. 2024 Jan;
4(12):e842-e852.
PMID: 38261392
Background: Prospective data about the risks of thrombotic and severe haemorrhagic complications during pregnancy and post partum are unavailable for women with antiphospholipid syndrome. We aimed to assess thrombotic and...
6.
Martin de Fremont G, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, et al.
Lancet Rheumatol
. 2024 Jan;
5(6):e330-e340.
PMID: 38251600
Background: Adverse pregnancy outcomes in women with primary Sjögren's syndrome have only been evaluated retrospectively using heterogeneous methods and with contradictory results. We aimed to describe adverse pregnancy, delivery, and...
7.
Delestre F, Charles P, Karras A, Pagnoux C, Neel A, Cohen P, et al.
Ann Rheum Dis
. 2023 Nov;
83(2):233-241.
PMID: 37918894
Objective: To compare the long-term efficacy and safety of azathioprine (AZA), 18-month fixed-schedule rituximab (RTX), 18-month tailored RTX and 36-month RTX in preventing relapses in patients with antineutrophil cytoplasmic antibody...
8.
Crickx E, Ebbo M, Riviere E, Souchaud-Debouverie O, Terriou L, Audia S, et al.
Br J Haematol
. 2023 May;
202(4):883-889.
PMID: 37247631
Combining drugs could be an effective option for treating multirefractory ITP, that is, patients not responding to rituximab, thrombopoietin receptor agonists (TPO-RA) and splenectomy. We conducted a retrospective, multicenter, observational...
9.
Stammler R, Bessis D, Meunier L, Limal N, Guillaud C, Mahevas M, et al.
J Eur Acad Dermatol Venereol
. 2023 Mar;
PMID: 36913246
No abstract available.
10.
Guillet S, Crickx E, Azzaoui I, Chappert P, Boutin E, Viallard J, et al.
Blood
. 2023 Mar;
141(23):2867-2877.
PMID: 36893453
Sustained response off treatment (SROT) after thrombopoietin receptor agonist (TPO-RA) discontinuation has been reported in immune thrombocytopenia (ITP). This prospective multicenter interventional study enrolled adults with persistent or chronic primary...